In our view, FMC is at risk for a dividend cut. Should FMC not see profit growth in 2025 and 2026 as expected, the dividend may be reduced or cut alltogether. FMC pays a little less than $300 million ...
D.C.’s Vanda Pharmaceuticals Inc. has locked in a deal with a West Coast biotech to commercialize a drug for a rare skin ...
Quantum BioPharma (NASDAQ: QNTM) announced the successful completion of a clinical trial demonstrating that its dietary supplement, unbuzzdTM, signi ...
Hangover Relief: Participants in this study noted a statistically significant reduction in hangover symptoms. This included reduced cognitive and physical impairment, and reduced headache compared to ...
Vanda expects to immediately begin preparing BLA and MAA applications for the U.S. and EU.
Zacks.com on MSN5d
Axsome Gets FDA Nod for New Migraine Drug Symbravo, Stock RisesAxsome Therapeutics, Inc. AXSM announced that the FDA has approved Symbravo (meloxicam and rizatriptan) for the acute ...
Tesla, Inc. is betting on Full Self-Driving and the Optimus humanoid robot for future growth, with significant potential ...
Musk announced that unsupervised Full Self Driving (FSD) would launch as a paid service in Austin by June 2025, with plans to expand across the U.S. This includes Tesla's internal fleet already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback